Daily News Podcast

FDA approval for 2 HIV drugs


 

The FDA approves the once-daily oral drugs Delstrigo and Pifeltro for HIV-1 infection. Also today, emicizumab beats factor VIII prophylaxis by a wide margin, orodental issues are often associated with facial port-wine stains, and epilepsy often accompanies congenital Zika infections. Subscribe to the MDedge Daily News wherever you get your podcasts.
Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

An epidemic of non-alcoholic fatty liver disease
MDedge ObGyn
Sleepio app tied to reducing insomnia, depression
MDedge ObGyn
5 digital HIPAA myths
MDedge ObGyn
Screen for cervical cancer based on age, risk
MDedge ObGyn
Is it time for PCPs to take over chronic HCV?
MDedge ObGyn
Rivaroxaban data abound at ESC 2018
MDedge ObGyn
New MI definition for infarction vs injury
MDedge ObGyn
Lorcaserin shows cardiovascular safety
MDedge ObGyn
Lung function decline linked to cardiovascular risk
MDedge ObGyn
Rivaroxaban beats aspirin for VTE
MDedge ObGyn